Adrian Parton, MBE, of Boundary Capital has backed Capital Cell, Europe’s first dedicated Life Sciences crowdfunding platform. Capital Cell works with companies whose technology is based on biology or healthcare to secure the investment they need to progress their innovative, potentially life-changing ideas. Capital Cell’s model is to support early stage companies, with seed stage…

It’s easy to see how early-stage tech VC investing can make arguably the largest returns. If you get it right investing in a disruptive business like WhatsApp or Alibaba can generate huge exits: a whopping $22Bn and $25Bn respectively (Sequoia Capital turned $60 million into $3 billion thanks to WhatsApp). And not just in The…

Investors are looking for alternative strategies and techniques to improve earnings and reduce risk. We will look at how businesses can optimise their business model and gain traction for long-term sustainable growth – for the investor this means less risk, less capital needed and plenty of added value. Who is the event for? This event…

Portfolio company Pure Potions continue to go from strength to strength with products now being stocked in leading retailers Boots, QVC, Waitrose and Holland & Barrett. Pure Potions make products formulated especially for use by those prone to dry skin. Their creams, ointments and oils are made from the very finest ingredients – many of…

Boundary investee Dymag has launched its new BOXSTROMTM carbon hybrid auto wheel aimed at OEMs and the aftermarket in early November. The wheel is typically 40% lighter than standard cast wheels and 25% lighter than forged wheels yet fully meets the relevant testing standards. To achieve this Dymag developed several patent-pending innovations for the new…

Boundary has partnered with advisers Yati Capital, to create investment streams from India and provide geographic reach to portfolio companies. Boundary has already secured additional investment as a result of the new partnership into their AngelPlus Fund, from Indian entrepreneur Rajneesh Bhandari. Rajneesh Bhandari is a first generation serial entrepreneur and has promoted four successful ventures in Telecommunication,…

Boundary Capital is delighted to be partnering the Kuber Aristotle EIS/SEIS Roadshow. A world of diversification in one place. The Kuber Aristotle Roadshow clearly exemplifies “the whole is greater than the sum of its parts” with 9 managers on the road showcasing a collective strength and depth covering a multitude of different industries and sectors…

Come and join Karren Brady, 100s of private investors, dozens of fund managers and around 450 other delegates at The WiseAlpha VCT & EIS Investor Forum 2016, 24th November, Bishopsgate, London. Boundary Capital will be leading a special debate on the day called: Some Like it Hot! Where can you make the best returns by…

Boundary Capital has announced its latest investment in Precision Sports Technology, a business which has the potential to disrupt the professional and amateur sports markets. Precision Sports Technology has developed innovative hardware and software which can be used in live competition by athletes to predict injury and fatigue. It does this by taking life signs…

Gene editing is one of hottest areas of life sciences. Many scientists are working towards using CRISPR technology to provide genetic solutions to conditions by literally editing the DNA in the genes. Desktop Genetics provides gene editing software (SaaS and on-prem) to make CRISPR gene editing easy and cost-effective. With their platform, DESKGEN, scientists can…

Boundary Capital Partners LLP is authorised and regulated by the Financial Conduct Authority.
Boundary Capital Partners LLP Reg: OC387581 VAT: 204012873
Registered office: 35 Kingsland Road, London, England, E2 8AA

STAY CONNECTED WITH US: